Xarelto: Global Drug Analysis 2017 with Forecasts to 2026 - ResearchAndMarkets.com

DUBLIN--()--The "Drug analysis: Xarelto" drug pipelines has been added to ResearchAndMarkets.com's offering.

Xarelto (rivaroxaban; Bayer/Johnson & Johnson) is an oral anticoagulant indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in the US, EU, and Japan. It inhibits free factor Xa, which interrupts the blood coagulation cascade, preventing both thrombin generation and thrombus formation. Xarelto inhibits prothrombinase activity and thrombin-induced platelet aggregation, thus reducing blood clots.

Key Topics Covered:

Product Profiles

  • Xarelto: Venous thromboembolism (VTE)
  • Xarelto: Chronic heart failure (CHF)
  • Xarelto: Stroke
  • Xarelto: Stroke prevention in atrial fibrillation (SPAF)
  • Xarelto: Acute coronary syndrome (ACS)

List of Figures (16 in Total)

Figure 1: Xarelto for venous thromboembolism - SWOT analysis

Figure 2: Drug assessment summary of Xarelto for venous thromboembolism

Figure 3: Drug assessment summary of Xarelto for venous thromboembolism

Figure 4: Xarelto sales forecast for VTE in the US, Japan, and five major EU markets, by country, 2017-26

List of Tables (16 in Total)

Table 1: Xarelto drug profile

Table 2: Xarelto pivotal trial data in venous thromboembolism

Table 3: Xarelto late-phase trial data in venous thromboembolism

Table 4: Xarelto sales for VTE in the US, Japan, and five major EU markets, by country ($m), 2017-26

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/cm6skv/xarelto_global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs